The etiopathogenesis of ulcerative colitis and its management by Ayurvedic treatment

Study on the etiopathogenesis of ulcerative colitis and its management by Ayurvedic formulation - SEUCAF

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031559

Enrollment

Registered

2021-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K922- Gastrointestinal hemorrhage, unspecified

Interventions

Intervention1: NIL: NIL Intervention2: Nilotapaldi Yoga in Oral Form and Piccha basti.: Group B - These patients will be treated with- 1. Nilotpaladi Yoga (Ca. Ch. 19 75) Nilakamala (Nymphaea nouchal

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: Mild to moderate type (Mayo score 3-10) of Ulcerative colitis patients irrespective of age and sex

Exclusion criteria

Exclusion criteria: Exclusion criteria: • Toxic mega colon/ Fulminant type of disease • Severe type of Ulcerative colitis (Mayo score 11-12) • Active ulcerative colitis • Known active infection (TB, HIV, C. Dificille, CMV) • Gastro intestinal perforation • Infective colitis, ischemic colitis, solitary ulcer syndrome, irradiation colitis

Design outcomes

Primary

Measure	Time frame
50 patientsTimepoint: 4 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactA C Kar

Faculty of Ayurveda, Institute of medical Sciences, Banaras Hindu University

ravidabas1988@gmail.com7565087467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026